New Ipsos-World Economic Forum survey following the release of a vaccine in the U.S. and U.K finds intentions to get vaccinated up in both countries, but down in several others as many worry about side effects.
This has been a year of momentous change – real and anticipated. As we pause to reflect at the end of the year, we present some Ipsos research highlights you may have missed during the dizzying events of 2020.
The success of a COVID-19 vaccine is one of the biggest challenges we face globally. This paper explores the opportunities and obstacles that lie ahead.
Our new 27-country survey finds rising levels of satisfaction and trust in health services as the world battles against the coronavirus pandemic. Waiting times and lack of staff are the main challenges perceived by the public.
Most adults across 15 countries don’t expect a vaccine to be available any sooner than mid-2021; only half would get vaccinated within three months of its availability.
As the race to develop a COVID-19 vaccine continues at speed, the world faces many more questions than answers – not only about when we might have a vaccine, but who will get it first, how will they get it and are they willing to have it? And how far will it take us on the journey back to ‘normal’…?